Editor’s note: This is a developing news story. Please check back soon for updates.
The FDA approved an expanded age indication for the EVO/EVO+ Visian Implantable Collamer Lens in the U.S.
Previously approved for patients between the ages of 21 to 45 years, the EVO ICL is now available for use in patients between the ages of 21 to 60 years, according to a press release from STAAR Surgical.
The EVO ICL is indicated in phakic eyes to correct/reduce myopia in those with spherical equivalent ranging from –3 D to –20 D at the spectacle plane, myopic astigmatism correction in those with spherical